Corcept Therapeutics Incorporated (CORT)

Operating profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Operating income US$ in thousands 136,951 107,282 112,634 124,477 128,202
Revenue US$ in thousands 675,040 482,375 401,858 365,978 353,874
Operating profit margin 20.29% 22.24% 28.03% 34.01% 36.23%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $136,951K ÷ $675,040K
= 20.29%

The operating profit margin of Corcept Therapeutics Incorporated has shown a declining trend over the past five years. Starting at 36.23% on December 31, 2020, the margin decreased to 20.29% by December 31, 2024. This downward trend indicates that the company's operating efficiency in generating profits from its core business operations has decreased over time. It is essential for the company to closely monitor its operating expenses and revenue generation strategies to potentially reverse this trend and improve profitability in the future.